A software application for comparing large numbers of high resolution MALDI-FTICR MS spectra demonstrated by searching candidate biomarkers for glioma blood vessel formation

BackgroundA Java™ application is presented, which compares large numbers (n > 100) of raw FTICR mass spectra from patients and controls. Two peptide profile matrices can be produced simultaneously, one with occurrences of peptide masses in samples and another with the intensity of common peak masses in all the measured samples, using the peak- and background intensities of the raw data. In latter way, more significantly differentially expressed peptides are found between groups than just using the presence or absence in samples of common peak masses. The software application is tested by searching angiogenesis related proteins in glioma by comparing laser capture micro dissected- and enzymatic by trypsin digested tissue sections.ResultsBy hierarchical clustering of the presence-absence matrix, it appears that proteins, such as hemoglobin alpha and delta subunit, fibrinogen beta and gamma chain precursor, tubulin specific chaperone A, epidermal fatty acid binding protein, neutrophil gelatinase-associated lipocalin precursor, peptidyl tRNA hydrolase 2 mitochondrial precursor, placenta specific growth hormone, and zinc finger CCHC domain containing protein 13 are significantly different expressed in glioma vessels. The up-regulated proteins in the glioma vessels with respect to the normal vessels determined by the Wilcoxon-Mann-Whitney test on the intensity matrix are vimentin, glial fibrillary acidic protein, serum albumin precursor, annexin A5, alpha cardiac and beta actin, type I cytoskeletal 10 keratin, calcium binding protein p22, and desmin. Peptide masses of calcium binding protein p22, Cdc42 effector protein 3, fibronectin precursor, and myosin-9 are exclusively present in glioma vessels. Some peptide fragments of non-muscular myosin-9 at the C-terminus are strongly up-regulated in the glioma vessels with respect to the normal vessels.ConclusionThe less rigorous than in general used commercial propriety software de-isotope algorithm results in more mono-isotopic peptide masses and consequently more proteins. Centroiding of peptide masses takes place by taking the average over more spectra in the profile matrix. Cytoskeleton proteins and proteins involved in the calcium signaling pathway seem to be most up-regulated in glioma vessels. The finding that peptides at the C-terminus of myosin-9 are up-regulated could be ascribed to splicing or fragmentation by proteases.

[1]  Eric Altermann,et al.  PathwayVoyager: pathway mapping using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database , 2005, BMC Genomics.

[2]  P. Collas,et al.  Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. , 2005, Molecular biology of the cell.

[3]  Tomasz Burzykowski,et al.  Using a Poisson approximation to predict the isotopic distribution of sulphur-containing peptides in a peptide-centric proteomic approach. , 2007, Rapid communications in mass spectrometry : RCM.

[4]  J. Yergey A GENERAL APPROACH TO CALCULATING ISOTOPIC DISTRIBUTIONS FOR MASS SPECTROMETRY. , 1983, Journal of mass spectrometry : JMS.

[5]  D. Hochstrasser,et al.  Modeling peptide mass fingerprinting data using the atomic composition of peptides , 1999, Electrophoresis.

[6]  F. McLafferty,et al.  High-resolution electrospray mass spectra of large molecules , 1991 .

[7]  Fredrik Levander,et al.  Modular, scriptable and automated analysis tools for high-throughput peptide mass fingerprinting , 2004, Bioinform..

[8]  J. Hartigan Multinomial Distribution , 2018, Definitions.

[9]  M. Senko,et al.  Determination of monoisotopic masses and ion populations for large biomolecules from resolved isotopic distributions , 1995, Journal of the American Society for Mass Spectrometry.

[10]  A. Marshall,et al.  Fourier transform ion cyclotron resonance mass spectrometry: a primer. , 1998, Mass spectrometry reviews.

[11]  Mark K. Titulaer,et al.  A database application for pre-processing, storage and comparison of mass spectra derived from patients and controls , 2006, BMC Bioinformatics.

[12]  R. C. Weast CRC Handbook of Chemistry and Physics , 1973 .

[13]  Yu Shyr,et al.  Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. , 2005, Cancer research.

[14]  P. Szymanski,et al.  Localization of Protein Regions Involved in the Interaction between Calponin and Myosin* , 1997, The Journal of Biological Chemistry.

[15]  H. Matsubara,et al.  Glia Maturation Factor-&ggr; Is Preferentially Expressed in Microvascular Endothelial and Inflammatory Cells and Modulates Actin Cytoskeleton Reorganization , 2006, Circulation research.

[16]  Identification of Glioma Neovascularization-related Proteins by Using MALDI-FTMS and Nano-LC Fractionation to Microdissected Tumor Vessels* , 2007, Molecular & Cellular Proteomics.

[17]  M. B. Comisarow,et al.  Error estimates for finite zero-filling in Fourier transform spectrometry , 1979 .

[18]  F. McLafferty,et al.  Automated reduction and interpretation of , 2000, Journal of the American Society for Mass Spectrometry.

[19]  Richard D. Smith,et al.  High mass measurement accuracy determination for proteomics using multivariate regression fitting: application to electrospray ionization time-of-flight mass spectrometry. , 2003, Analytical chemistry.

[20]  R. M. A. Heeren,et al.  Parallel processing of large datasets from NanoLC-FTICR-MS measurements , 2007, Journal of the American Society for Mass Spectrometry.